ATAGI 2023 booster advice

April 5th, 2023

Awake Goy

Key points:

ATAGI advises the following groups should consider a 2023 booster dose if their last COVID-19 vaccine dose or confirmed infection (whichever is the most recent) was 6 months ago or longer, and regardless of the number of prior doses received, based on an individual risk benefit assessment with their immunisation provider.

All Adults aged 18-64 years without risk factors for severe COVID-19
Children and adolescents aged 5-17 years who have medical comorbidities that increase their risk of severe COVID-19, or disability with significant or complex health needs.

ATAGI advises that a booster dose is not recommended at this time for children and adolescents aged under the age of 18 who do not have any risk factors for severe COVID-19.

See pdf:

Please also note that the pharmaceutic drug used to treat C-19 cannot be called vaccine as it does not confer immunity.

See U.S. Supreme Court case from 4th of November 2021:

<br />

See Pfizer document leak:

https://phmpt.org/pfizers-documents/

See article of the headline: